| Literature DB >> 20226569 |
Allison E Aiello1, Rebecca M Coulborn, Tomas J Aragon, Michael G Baker, Barri B Burrus, Benjamin J Cowling, Alasdair Duncan, Wayne Enanoria, M Patricia Fabian, Yu-hui Ferng, Elaine L Larson, Gabriel M Leung, Howard Markel, Donald K Milton, Arnold S Monto, Stephen S Morse, J Alexander Navarro, Sarah Y Park, Patricia Priest, Samuel Stebbins, Alexandra M Stern, Monica Uddin, Scott F Wetterhall, Charles J Vukotich.
Abstract
In June 2006, the Centers for Disease Control and Prevention released a request for applications to identify, improve, and evaluate the effectiveness of nonpharmaceutical interventions (NPIs)-strategies other than vaccines and antiviral medications-to mitigate the spread of pandemic influenza within communities and across international borders (RFA-CI06-010). These studies have provided major contributions to seasonal and pandemic influenza knowledge. Nonetheless, key concerns were identified related to the acceptability and protective efficacy of NPIs. Large-scale intervention studies conducted over multiple influenza epidemics, as well as smaller studies in controlled laboratory settings, are needed to address the gaps in the research on transmission and mitigation of influenza in the community setting. The current novel influenza A (H1N1) pandemic underscores the importance of influenza research. Copyright (c) 2010 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.Entities:
Mesh:
Year: 2010 PMID: 20226569 DOI: 10.1016/j.ajic.2009.12.007
Source DB: PubMed Journal: Am J Infect Control ISSN: 0196-6553 Impact factor: 2.918